| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,734 | 12,618 | 13,806 | 22,764 | | Cost of Revenue | 7,596 | 12,156 | 13,864 | 20,414 | | | Gross Profit | 1,138 | 462 | (58) | 2,350 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,478 | 6,772 | 4,699 | 4,181 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,340) | (6,310) | (4,757) | (1,831) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 420 | 382 | 455 | 605 | | Earnings Before Interest And Taxes | (2,920) | (5,928) | (4,302) | (1,226) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (2,920) | (5,928) | (4,302) | (1,226) | | Income Tax Expense | (1,312) | (2,093) | (1,816) | (100) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,608) | (3,835) | (2,486) | (1,126) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,608) | (3,835) | (2,486) | (1,126) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,608) | ($3,835) | ($2,486) | ($1,126) |
|
0.11% Nasdaq 
0.01%
Income Statement
